Other formats:
BibTeX
LaTeX
RIS
@article{1552256,
author = {Ševčíková, Sabina and Minarik, Jiri and Stork, Martin and Jelinek, Tomas and Pour, Ludek and Hajek, Roman},
article_location = {EDINBURGH},
article_number = {JUL 2019},
doi = {http://dx.doi.org/10.1016/j.blre.2019.04.002},
keywords = {Multiple myeloma; Extramedullary disease; Treatment; Resistance; Biomarker},
language = {eng},
issn = {0268-960X},
journal = {BLOOD REVIEWS},
title = {Extramedullary disease in multiple myeloma - controversies and future directions},
url = {http://dx.doi.org/10.1016/j.blre.2019.04.002},
volume = {36},
year = {2019}
}
TY - JOUR
ID - 1552256
AU - Ševčíková, Sabina - Minarik, Jiri - Stork, Martin - Jelinek, Tomas - Pour, Ludek - Hajek, Roman
PY - 2019
TI - Extramedullary disease in multiple myeloma - controversies and future directions
JF - BLOOD REVIEWS
VL - 36
IS - JUL 2019
SP - 32-39
EP - 32-39
PB - CHURCHILL LIVINGSTONE
SN - 0268960X
KW - Multiple myeloma
KW - Extramedullary disease
KW - Treatment
KW - Resistance
KW - Biomarker
UR - http://dx.doi.org/10.1016/j.blre.2019.04.002
L2 - http://dx.doi.org/10.1016/j.blre.2019.04.002
N2 - Extramedullary disease of multiple myeloma (EM) remains a treatment challenge even in the era of new drugs. While many reports analyzing various aspects of EM have been published, mechanism of EM development has not been clarified yet. This review summarizes current knowledge about this clinical entity, including its history, diagnostics, imaging methods, incidence, prognosis, current treatment options, risk factors and known molecular mechanisms that might be involved in pathogenesis of EM.
ER -
ŠEVČÍKOVÁ, Sabina, Jiri MINARIK, Martin STORK, Tomas JELINEK, Ludek POUR and Roman HAJEK. Extramedullary disease in multiple myeloma - controversies and future directions. \textit{BLOOD REVIEWS}. EDINBURGH: CHURCHILL LIVINGSTONE, 2019, vol.~36, JUL 2019, p.~32-39. ISSN~0268-960X. Available from: https://dx.doi.org/10.1016/j.blre.2019.04.002.
|
